Distributional Cost-Effectiveness Analysis of Treatments for Non-Small Cell Lung Cancer: An Illustration of an Aggregate Analysis and its Key Drivers. [PDF]
Pharmacoeconomics, 2023 Meunier A +5 more
europepmc +1 more source
Increasing transparency in indirect treatment comparisons: is selecting effect modifiers the missing part of the puzzle? A review of methodological approaches and critical considerations. [PDF]
J Comp Eff Res, 2023 Freitag A, Gurskyte L, Sarri G.
europepmc +1 more source
Challenges of modelling approaches for network meta-analysis of time-to-event outcomes in the presence of non-proportional hazards to aid decision making: Application to a melanoma network. [PDF]
Stat Methods Med Res, 2022 Freeman SC +5 more
europepmc +1 more source
Construction and initial characterization of Escherichia coli strains with few or no intact chromosomal rRNA operons. [PDF]
J Bacteriol, 1999 Asai T +7 more
europepmc +1 more source
An Escherichia coli strain with all chromosomal rRNA operons inactivated: complete exchange of rRNA genes between bacteria. [PDF]
Proc Natl Acad Sci U S A, 1999 Asai T +3 more
europepmc +1 more source
Promoter- and attenuator-related metabolic regulation of the Salmonella typhimurium histidine operon. [PDF]
J Bacteriol, 1978 Winkler ME, Roth DJ, Hartman PE.
europepmc +1 more source
Histidine regulation in Salmonella typhimurium. XV. Procedure for the selection of mutants unable to derepress the histidine operon. [PDF]
J Bacteriol, 1974 Straus DS, Wyche JH.
europepmc +1 more source
A fine structure map of the salmonella histidine operator-promoter. [PDF]
Genetics, 1974 Ely B, Fankhauser DB, Hartman PE.
europepmc +1 more source
Transportability of nonlocal real-world evidence and its relevance to health technology assessment: a primer. [PDF]
J Comp Eff ResGupta A +6 more
europepmc +1 more source